Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.

Simpson, Eric L; Blauvelt, Andrew; Silverberg, Jonathan I; Cork, Michael J; Katoh, Norito; Mark, Thomas; Schneider, Shannon K R; Wollenberg, Andreas

Simpson, Eric L; Blauvelt, Andrew; Silverberg, Jonathan I; Cork, Michael J; Katoh, Norito; Mark, Thomas; Schneider, Shannon K R; Wollenberg, Andreas.

Affiliation

Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Blauvelt A; Oregon Medical Research Center, Portland, OR, USA.
Silverberg JI; Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC, USA.
Cork MJ; Sheffield Dermatology Research, IICD, University of Sheffield, Sheffield, UK.
Katoh N; Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Mark T; LEO Pharma A/S, Ballerup, Denmark.
Schneider SKR; LEO Pharma Inc., Madison, NJ, USA.
Wollenberg A; Department of Dermatology and Allergology, Ludwig-Maximilian University, Frauenlobstrasse 9-11, 80337, Munich, Germany. wollenberg@lrz.uni-muenchen.de.

Am J Clin Dermatol ; 25(1): 139-148, 2024 Jan.

Article de En | MEDLINE | ID: mdl-37804473

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Eczéma atopique / Eczéma / Anticorps monoclonaux Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Adult / Humans Langue: En Journal: Am J Clin Dermatol Sujet du journal: DERMATOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google